Literature DB >> 8268918

Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization.

O Ibraghimov-Beskrovnaya1, A Milatovich, T Ozcelik, B Yang, K Koepnick, U Francke, K P Campbell.   

Abstract

Dystroglycan is a novel laminin binding component of the dystrophin-glycoprotein complex which provides a linkage between the subsarcolemmal cytoskeleton and the extracellular matrix. Here we report the cDNA and genomic structure of human dystroglycan. The human dystroglycan is encoded by a single gene (DAG1) mapped to chromosome 3 band p21. The coding sequence is organized into two exons, separated by a large intron. The predicted amino acid sequence of human and rabbit dystroglycan are 93% identical with predicted glycosylation sites being conserved. Human dystroglycan is expressed in a variety of fetal and adult tissues. Our data suggest that muscle and non-muscle isoforms of dystroglycan differ by carbohydrate moieties but not protein sequence. Therefore, we hypothesize that variable glycosylation of the conserved protein core might modulate laminin binding. The relationship of dystroglycan to human diseases is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8268918     DOI: 10.1093/hmg/2.10.1651

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  56 in total

1.  O Mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function.

Authors:  Mauro Imperiali; Claudio Thoma; Ernesto Pavoni; Andrea Brancaccio; Nico Callewaert; Annette Oxenius
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

2.  Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy.

Authors:  P H Vachon; H Xu; L Liu; F Loechel; Y Hayashi; K Arahata; J C Reed; U M Wewer; E Engvall
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 3.  The role of laminins in basement membrane function.

Authors:  M Aumailley; N Smyth
Journal:  J Anat       Date:  1998-07       Impact factor: 2.610

Review 4.  Laminin-211 in skeletal muscle function.

Authors:  Johan Holmberg; Madeleine Durbeej
Journal:  Cell Adh Migr       Date:  2012-11-15       Impact factor: 3.405

Review 5.  Finding the sweet spot: assembly and glycosylation of the dystrophin-associated glycoprotein complex.

Authors:  Dewayne Townsend
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

6.  Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes.

Authors:  Masaharu Iwasaki; Shuzo Urata; Yoshitake Cho; Nhi Ngo; Juan C de la Torre
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

Review 7.  Pathogenesis of proteinuria in idiopathic minimal change disease: molecular mechanisms.

Authors:  Gabriel Cara-Fuentes; William L Clapp; Richard J Johnson; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2016-07-06       Impact factor: 3.714

8.  Alterations of dystrophin-associated glycoproteins in the heart lacking dystrophin or dystrophin and utrophin.

Authors:  Katharine M Sharpe; Monica D Premsukh; DeWayne Townsend
Journal:  J Muscle Res Cell Motil       Date:  2013-10-06       Impact factor: 2.698

9.  Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.

Authors:  Alison K Esser; Michael R Miller; Qin Huang; Melissa M Meier; Daniel Beltran-Valero de Bernabé; Christopher S Stipp; Kevin P Campbell; Charles F Lynch; Brian J Smith; Michael B Cohen; Michael D Henry
Journal:  J Biol Chem       Date:  2012-12-06       Impact factor: 5.157

Review 10.  Aquaporin expression in normal and pathological skeletal muscles: a brief review with focus on AQP4.

Authors:  Yoshihiro Wakayama
Journal:  J Biomed Biotechnol       Date:  2010-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.